This event is hosted by the LSHTM Cancer Survival Group and is part of the London Global Cancer Week 2023. The CONCORD programme documented wide global differences in survival trends, still persistent in 2010-2014, for women diagnosed with breast cancer (66% in India; over 90% in the US and Australia), cervical (52% in Ecuador; 77% in Korea) or ovarian (16% in India; 57% in Costa Rica) cancers.